The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung Disease @checkrare
The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung Disease  @checkrare
Uploaded November 2026 | Updated November 2026, 3 days ago
Parth Rali, MD, MBBS, FCCP, pulmonologist at Temple Health, discusses interim findings from the PHINDER study evaluating pulmonary hypertension (PH) screening strategies in patients with interstitial lung disease (ILD).

Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseFabry Disease: Patients Real-World Problems and How to ManageLipodystrophy Research Presented at ENDO 2026Diagnosis and Treatment of IGF-1 DeficiencyPhase 2a GATEWAY Trial of PORT-77 in Patients With Erythropoietic Protoporphyria Shows PromiseEpisode 1: FDA Advisory Board’s Concerns About New Duchenne Drug, Brain Fog in Immune Thrombocyto...Approval of Imaavy (Nipocalimab) and its Impact on Patients With Warm Autoimmune Hemolytic AnemiaFDA Approves Multiple Myeloma Drug;  FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-W...Follow-Up Data of Safusidenib in Patients With IDH-Mutant GliomasWhat the Approval of IMAAVY Means for Patients With wAIHAUltragenyx Sells PRV for $210M | The CheckRare Brief Ep 11Fabry Disease: Is The Risk of Stroke or Heart Failure Being Properly Managed By Your Medical Team?
CheckRare |

The Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung Disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER